U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV
Go back to U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV| Pfizer Inc. (NYSE: PFE) | Delayed: 28.78 +0.11 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.67 | 52 Week High | $37.39 | |||
| Open | $28.62 | 52 Week Low | $28.25 | |||
| Day High | $28.78 | P/E | 17.44 | |||
| Day Low | $28.39 | EPS | $1.65 | |||
| Volume | 13,317,395 | |||||
